Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2014

Pacific Green Technologies, Inc. (PGTK) Leverages Achievements of 2013 for Success in 2014

Pacific Green Technologies, in its mission to address the world’s need for cleaner and more sustainable energy, operates through three divisions individually focused on various aspects in support of the company’s overarching objective through: • The design, development, licensing, and … Continue reading

Posted in Small Cap News | Leave a comment

Chanticleer Holdings, Inc. (HOTR) Announces Plans to Purchase First U.S. Hooters Restaurants

Chanticleer Holdings is a public company that was formed in 2005 as a business development company and converted to an operating holding company in 2008. It owns and operates various restaurant brands in the United States and abroad, but though … Continue reading

Posted in Chanticleer Holdings Inc. HOTR | Leave a comment

Avino Silver & Gold Mines Ltd. (ASM) Video Chart for Wednesday, January 22, 2014

ASM made a breakout move on Tuesday, pushing above a resistance point at $1.29 to close the day ahead by 15.6 percent at $1.47. The next resistance is at $1.60, but not much more until the next level at a … Continue reading

Posted in Technical Analysis | Leave a comment

Shareholders Approve Overland Storage’s (OVRL) Acquisition of Tandberg Data

Trusted global unified data management and data protection solutions provider Overland Storage announced it has received the needed shareholder votes to complete its acquisition of Tandberg Data Holdings S.à r.l. Tandberg Data is a privately held global data storage and … Continue reading

Posted in Small Cap News | Leave a comment

VolitionRx Ltd. (VNRX) Announces Start of First Large Clinical Trial in Collaboration with Hvidovre Hospital, Denmark

Today before the opening bell, VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, announced it has commenced blood sample analysis for its largest clinical study to date, in collaboration with Hvidovre … Continue reading

Posted in VolitionRx Ltd. VNRX | Leave a comment

Jameson Stanford Resources Corp. (JMSN) Leverages Strong Management Experience for Rock-solid Gains

Based out of Las Vegas, Nevada, Jameson Stanford Resources is a publicly held mining company that is concentrating its efforts on mining sites located within Utah’s historic mining districts. The company targets historical mines with strong production and future growth … Continue reading

Posted in Jameson Stanford Resources Corp. JMSN | Leave a comment

Boston Therapeutics, Inc. (BTHE) Prepares for Third Phase Trial of PAZ320

Boston Therapeutics is a pharmaceutical company focused on the development, manufacturing, and commercialization of novel compounds based on complex carbohydrate chemistry to address unmet medical needs in diabetes. PAZ320 is an integral part of the company’s initial product pipeline, which … Continue reading

Posted in Boston Therapeutics Inc. BTHE | Leave a comment

Kindred Biosciences, Inc. (KIN) Primed to Release Several Safe and Effective Pet Medicines, Directly Addressing Unserved/Underserved Demand

Kindred Biosciences, while still a development stage biopharma, has crafted an ingenious business strategy for cost-effectively ramping towards solid revenues through the formulation of therapies for dogs, cats, horses, and other pets, using compounds which are already validated in human … Continue reading

Posted in Small Cap News | Leave a comment

Harvard Apparatus Regenerative Technology’s (HART) Lab-Grown Organ Technology Featured in MIT Technology Review

Clinical-stage biotechnology company Harvard Apparatus Regenerative Technology, Inc. announced it has been featured in an article published by MIT Technology Review that was published on Jan. 16, 2014. Entitled “Manufacturing Organs,” the article highlighted HART’s new focus and noted the … Continue reading

Posted in Small Cap News | Leave a comment

VistaGen Therapeutics, Inc. (VSTA) Human Pluripotent Stem Cell Technology is the Backbone of Promising Development Strategy

Human Clinical Trials in a Test Tube™ — sounds like something out of a science fiction movie, but as it turns out, this is science reality. VistaGen Therapeutics is the developer of this versatile human pluripotent stem cell (hPSC) technology … Continue reading

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment